Literature DB >> 6541750

Cis-platinum-induced renal sodium wasting.

P J Lammers, L White, L J Ettinger.   

Abstract

A 10-year-old girl with a malignant ovarian germ cell tumor was treated with cis-platinum-based chemotherapy. During the third and fourth courses of therapy, the patient developed hyponatremia, hypomagnesemia, and hypocalcemia. Renal sodium wasting was documented to be the cause of the hyponatremia. Despite normalization of serum electrolytes, hyponatremia again occurred during a period of stress following cessation of cis-platinum. Prior work has documented that cis-platinum-induced hypomagnesemia is related to renal tubular dysfunction with resulting magnesium wasting. A similar etiology for cis-platinum-induced hyponatremia and renal sodium wasting is proposed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541750     DOI: 10.1002/mpo.2950120509

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

Review 1.  Cisplatin nephrotoxicity. A review.

Authors:  G Daugaard; U Abildgaard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

4.  Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

Authors:  C R Thomas; K J Stelzer; J G Douglas; W J Koh; L V Wood; R Panicker
Journal:  J Natl Med Assoc       Date:  1994-11       Impact factor: 1.798

Review 5.  Cytostatics--induced tubular toxicity.

Authors:  M Brandis; K von der Hardt; R B Zimmerhackl; M Mohrmann; J Leititis
Journal:  Clin Investig       Date:  1993-10

Review 6.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 7.  Mechanisms of Cisplatin nephrotoxicity.

Authors:  Ronald P Miller; Raghu K Tadagavadi; Ganesan Ramesh; William Brian Reeves
Journal:  Toxins (Basel)       Date:  2010-10-26       Impact factor: 4.546

8.  Cisplatin dose rate as a risk factor for nephrotoxicity in children.

Authors:  R Skinner; A D Pearson; M W English; L Price; R A Wyllie; M G Coulthard; A W Craft
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

9.  Cisplatin-Induced Renal Salt Wasting Requiring over 12 Liters of 3% Saline Replacement.

Authors:  Phuong-Chi Pham; Pavani Reddy; Shaker Qaqish; Ashvin Kamath; Johana Rodriguez; David Bolos; Martina Zalom; Phuong-Thu Pham
Journal:  Case Rep Nephrol       Date:  2017-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.